IGF1 and ovarian carcinoma: (2) Brokaw et al. 54 reported that women with high IGF-I mRNA and IGF-1 peptide levels were at a greater risk for disease progression compared to those with low levels, suggesting that IGF-I is involved in ovarian cancer progression.